Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

GlaxoSmithKline PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Jan 2016 Reuters Investment Profile 12 $20.00

GlaxoSmithKline PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Jan 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - GlaxoSmithKline PLC (GSK-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 Feb 2016 Thomson Reuters Stock Report 11 $25.00

Trading Report for (GSK). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for GSK. Entry levels, target prices, and risk controls are integral. In addition, free market analy...

05 Feb 2016 Stock Traders Daily 6 $20.00

GSK: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

05 Feb 2016 New Constructs, LLC 10 $25.00

GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review Summary GlaxoSmithKline plc (GSK) is a healthcare co...

03 Feb 2016 GlobalData 721 $300.00

ValuEngine Rating and Forecast Report for GSK

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

31 Jan 2016 ValuEngine, Inc. 11 $25.00

GLAXOSMITHKLINE PLC (GSK=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

30 Jan 2016 Pechala's Reports 2 $25.00

Validea Guru Analysis Report for GSK. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

29 Jan 2016 Validea 0 $12.00

Value Graph: GLAXOSMITHKLINE -- GSK

29 Jan 2016 Ford Investor Services, Inc. 1 $12.00